1.Plain chest diagnosis of respiratory disease.
Tuberculosis and Respiratory Diseases 1993;40(4):353-356
No abstract available.
Diagnosis*
;
Thorax*
2.The Evaluation of Thyroid Function Test.
Journal of the Korean Geriatrics Society 1999;3(2):19-27
No abstract available.
Thyroid Function Tests*
;
Thyroid Gland*
4.CT Findings of Bronchioloalveolar Carcinoma.
Journal of the Korean Radiological Society 1995;32(5):717-723
PURPOSE: We studied CT findings of bronchioloalveolar carcinoma that manifestated varied clinical and radiologic characteristics. MATERIALS & METHODS: We studied presenting radiographic patterns and their characteristics and secondary findings of histologically proven 30 cases of bronchioloalveolar carcinomas on chest CT scan. RESULTS: Bronchioloalveolar carcinoma appeared radiologically as a solitary nodule(19 cases), consolidation (7 cases), and multinodules(4 cases). A solitary nodular type shows irregular or spiculated borders, peripheral or subpleural location, heterogenous density, pleural tags, pseudocavitation, and sometimes rim-enhancement of mass. A consolidation type shows air-brochogram, pseudocavitation and CT anglogram within homogenous low attenuated consolidated lung. Hilar and mediastinal lymphadenopathy as secondary findings of bronchioloalveolar carcioma appeared frequently(43.3%). Even in a solitary nodular form, hilar & mediastinal lymphadenopathy was noted in 36.8% and follow-up study in 6 cases showed lung-to-lung metastasis with 14.7 months in mean metastasis duration. CONCLUSION: It is difficulty in diagnosis of bronchioloalveolar carcioma with clinical or plain radiographic features alone because of theis variability. We found that CT scan can help the diagnosis of this tumor. We also found out that a solitary form of bronchioloalveolar carcioma as well as diffuse form does not have a good prognosis.
Adenocarcinoma, Bronchiolo-Alveolar*
;
Diagnosis
;
Follow-Up Studies
;
Lung
;
Lymphatic Diseases
;
Neoplasm Metastasis
;
Prognosis
;
Tomography, X-Ray Computed
5.What is the Cause of Low End: Tidal CO2 Tension During General Endotracheal Anesthesia?.
Korean Journal of Anesthesiology 1996;30(2):238-239
BACKGROUND: We have previously demonstrated the isoflurane and halothane may be detrimental to in vitro fertilization of mouse oocytes in high concentrations. The aim of this study is to compare the toxic effects of volatile anesthetics on mouse embryos using in vitro growth model of two cell mouse embryos. METHODS: Mouse two-cell embryos exposed to three volatile anesthetics, enflurane(0.5 mM; 1.5 mM), isoflurane(0.26 mM; 0.78 mM) and halothane(0.24 mM; 0.72 mM). Mouse two-cell embryos unexposed to any drugs were included as controls. RESULTS: The percentages of two-cell mouse embryos developed over morula stages on the third day after exposure of high concentrations of isoflurane and halothane decreased significantly compared with controls. The rates of embryos arrested at 2-8 cell stage in these groups were significantly higher than that of controls. There were no significant differences in these rates between enflurane group, isofiurane and halothane group of lower concentrations and controls. The hatching and/or hatched blastocysts development were significantly lower in isoflurane and halothane group than in controls. No significant differences in the hatching rate of blastocyst developed were observed among groups. CONCLUSIONS: Our data show that isoflurane and halothane in high concentrations have harm effects of the in vitro growth of two cell mouse embryos.
Anesthesia*
;
Anesthetics
;
Animals
;
Blastocyst
;
Embryonic Development
;
Embryonic Structures
;
Enflurane
;
Female
;
Fertilization in Vitro
;
Halothane
;
Isoflurane
;
Mice
;
Morula
;
Oocytes
;
Pregnancy
6.What is the Cause of Low End: Tidal CO2 Tension During General Endotracheal Anesthesia?.
Korean Journal of Anesthesiology 1996;30(2):238-239
BACKGROUND: We have previously demonstrated the isoflurane and halothane may be detrimental to in vitro fertilization of mouse oocytes in high concentrations. The aim of this study is to compare the toxic effects of volatile anesthetics on mouse embryos using in vitro growth model of two cell mouse embryos. METHODS: Mouse two-cell embryos exposed to three volatile anesthetics, enflurane(0.5 mM; 1.5 mM), isoflurane(0.26 mM; 0.78 mM) and halothane(0.24 mM; 0.72 mM). Mouse two-cell embryos unexposed to any drugs were included as controls. RESULTS: The percentages of two-cell mouse embryos developed over morula stages on the third day after exposure of high concentrations of isoflurane and halothane decreased significantly compared with controls. The rates of embryos arrested at 2-8 cell stage in these groups were significantly higher than that of controls. There were no significant differences in these rates between enflurane group, isofiurane and halothane group of lower concentrations and controls. The hatching and/or hatched blastocysts development were significantly lower in isoflurane and halothane group than in controls. No significant differences in the hatching rate of blastocyst developed were observed among groups. CONCLUSIONS: Our data show that isoflurane and halothane in high concentrations have harm effects of the in vitro growth of two cell mouse embryos.
Anesthesia*
;
Anesthetics
;
Animals
;
Blastocyst
;
Embryonic Development
;
Embryonic Structures
;
Enflurane
;
Female
;
Fertilization in Vitro
;
Halothane
;
Isoflurane
;
Mice
;
Morula
;
Oocytes
;
Pregnancy
7.Association Between Infection of Human Papillomavirus and Decreased Expression of Cyclin DI in Cervical Neoplasia.
Korean Journal of Gynecologic Oncology and Colposcopy 1999;10(4):315-323
Cyclin Dl, one of Gl cyclin gene subfamily, and human papillomaviruses (HPV) oncoprotein E7 have a homology in binding sites for the retinoblastoma tumor-suppressor protein. In order to evaluate the role of cyclin Dl in human cervical carcinogenesis, the level of its expression was measured and compared to HPV infection. In these studies, 38 normal control cases, 22 carcinoma in situ (CIN) cases, and 16 invasive cervical carcinomas were analyzed by immunocytochemistry and polymerase chain reactions for the detection of expression of cyclin Dl and infection of HPV type 16 and 18, respectively. The cyclin Dl expression was significantly lower in CIN and invasive carcinoma than normal control group regardless of HPV infection (p=0.026). The decreased expression of cyclin Dl in normal control group was not related with HPV infection. However, the levels of expression of cyclin Dl in CIN and invasive carcinoma were correlated with HPV 16and 18 (p 0.026). The expression of cyclin E was not changed in HPV 16 and 18 infected cases. These data provide the evidence that cyclin Dl expression in the lesions of cervical tumor is decreased and it is related with HPU infection.
Binding Sites
;
Carcinogenesis
;
Carcinoma in Situ
;
Cyclin E
;
Cyclins*
;
Human papillomavirus 16
;
Humans*
;
Immunohistochemistry
;
Polymerase Chain Reaction
;
Retinoblastoma
8.WEHI-231 cells are defective in the ligand-induced internalization of B cell antigen receptor.
Immune Network 2001;1(3):196-202
No abstract available.
Receptors, Antigen*
9.Expression of Fragile Histidine Triad (FHIT) Gene Product in the Uterine Cervical Carcinoma.
Korean Journal of Gynecologic Oncology and Colposcopy 1999;10(3):217-223
To investigate the involvement of expression of the Fragile Histidine Triad(FH1T) gene product in the process of carcinogenesis and progression in cervical carcinoma, we examined its expression by immunohistochemical method in 15 cervical invasive carcinomas, 10 low grade cervical intraepithelial neoplasias(CINs) and 30 high grade CINs(CMI and III). We detected expression of FHIT gene product in 4 of 15(27%) of invasive carcinomas, 3 of 10(30%) low grade CIN and 7 of 30(23%) of high grade CIN, while we detected expression of FHIT gene product in 28 of 45(62%) normal and metaplastic epithelium near the tumor. Thesc data indicate that loss of expression of FH1T gene product has some role in the early tumorigenesis of uterine cervical carcinoma, but not the consequence of the pregression of the tumor.
Carcinogenesis
;
Epithelium
;
Histidine*
;
Immunohistochemistry